Stay updated on Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.1 label is added to the page footer, and Revision: v3.4.0 label is removed.
    Difference
    0.0%
    Check dated 2026-02-06T13:02:11.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Glossary toggle options were added (Show glossary/Hide glossary) and the page revision updated from v3.3.4 to v3.4.0 with related Last Update metadata changes; these are minor UI/metadata changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-23T10:20:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; this is an administrative update with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T05:00:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a new 2025 Blood Advances publication on risk stratification of low-dose cytarabine and venetoclax in AML ineligible for intensive chemotherapy; updated author designation for the related Blood Advances citation.
    Difference
    0.0%
    Check dated 2026-01-02T00:54:00.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Locations section now includes numerous new study sites across multiple countries and regions (e.g., Florida, Kentucky, Brussels, Tokyo, Buenos Aires, etc.), with several prior sites removed, altering where participants can enroll.
    Difference
    2%
    Check dated 2025-12-18T20:51:57.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Low Dose Cytarabine in AML Clinical Trial page.